文献速递胃肠外科围术期管理与 ERAS

COVID-19诊断与减重手术人群:单中心经验

Diagnosis of COVID-19 and the bariatric surgery population: a single center experience.
PubMed 文献 · Surg Endosc · 2021-01-25

本研究为单中心横断面研究,纳入2020年1月1日至3月18日接受减重手术的190例患者,通过电话调查了解围手术期COVID-19暴露、症状和检测情况。作者认为尽管无重症,但症状与手术带来的医疗暴露时间关系提示择期手术可能增加疾病风险。

要点

  • 减重手术患者术后30天内10.7%报告COVID-19兼容症状,3.4%检测阳性。
  • 本组无COVID-19相关住院或死亡,未观察到重症疾病。
  • 症状出现与手术所致医疗系统暴露增加的时间关系提示择期手术可能增加风险。

核心结论

  • 接受减重手术的患者在术后30天内报告COVID-19兼容症状的比例为10.7%,检测阳性率为3.4%,但无COVID-19相关住院或死亡。
  • 症状出现与手术导致的医疗系统暴露增加存在时间关联,提示择期手术可能增加疾病风险。

研究设计与样本

  • 单中心横断面研究,纳入2020年1月1日至2020年3月18日接受减重手术的患者。

主要发现

  • 腹腔镜袖状胃切除术是最常见术式,占71.6%。
  • 术后19例(10.7%)报告COVID-19兼容症状,6例(3.4%)检测阳性。
  • 无COVID-19相关住院或死亡。

临床怎么用

  • 在COVID-19大流行演变期,对减重手术患者应加强围手术期COVID-19症状监测和检测。
  • 择期减重手术需权衡手术带来的医疗暴露风险与患者获益。

局限性

  • 单中心设计可能限制结果外推性。
  • 依赖电话调查获取症状和检测信息,可能存在回忆偏倚。
  • 样本量有限,且为横断面研究,无法确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While many cases of the coronavirus disease 2019 (COVID-19) are mild, patients with underlying medical conditions such as hypertension (HTN), diabetes mellitus (DM), older age, and morbid obesity are at higher risk of hospitalization and death. These conditions are characteristic of patients eligible for bariatric surgery, many of whom underwent weight loss procedures in the months prior to cessation of elective surgery in March 2020. The effects of the virus on these high-risk patients who had increased healthcare exposure in the early days of the pandemic are currently unknown. OBJECTIVES: To describe the experience of patients who underwent bariatric surgery during the early evolution of the COVID-19 pandemic. METHODS: This is a cross-sectional study including patients from a single center who underwent bariatric surgery from January 1st, 2020 to March 18th, 2020. A database was created to analyze patients' demographics, operative variables, and postoperative outcomes. All patients were contacted and a telephone survey was completed to inquire about COVID-19 exposure, symptoms, and testing 30 days before and after surgery. RESULTS: A total of 190 patients underwent bariatric surgery during the study period. Laparoscopic sleeve gastrectomy was the most common procedure (71.6%). One hundred seventy-eight patients (93.7%) completed the telephone survey. Postoperatively, 19 patients (10.7%) reported COVID-19 compatible symptoms, and six patients (3.4%) went on to test positive for COVID-19. There were no COVID-19-related hospital admissions or mortalities in this population. CONCLUSIONS: Morbidly obese patients are at high risk of severe disease secondary to COVID-19, and those undergoing bariatric surgery during the evolution of the pandemic reported symptoms at a rate of 10.7% 30 days after the surgery. While none of these patients suffered severe COVID-19 disease, the temporal relationship of their symptomatology and increased exposure to the healthcare system as a result of their surgery suggest an increased risk of disease with elective surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Romero-Velez G, Pereira X, Skendelas JP, et al. Diagnosis of COVID-19 and the bariatric surgery population: a single center experience. Surg Endosc. 2021. PMID: 33492513. doi:10.1007/s00464-020-08249-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。